share_log

Bharat Biotech has Completed Phase 2 and 3 Clinical Trials of Covaxin for Use in Children 2 to 18 Years; Chairman Krishna Ella said Covaxin Production would Reach 55M Doses in October vs 35M in Septem

Benzinga Real-time News ·  Sep 21, 2021 05:14

Live Mint https://www.livemint.com/news/india/bharat-biotech-completes-covaxin-phase-2-3-clinical-trials-for-children-11632213730051.html

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment